APO Research
Talk to an analyst

APO RESEARCH · REPORT

Thrombin (Human)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Thrombin (Human) Industry Growth and Trends Forecast to 2032

26 December 2025109 pages

Choose your research edition.

Industry ResearchThrombin (Human) Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Thrombin (Human) Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Thrombin (Human) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Thrombin (Human) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Thrombin (Human) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Thrombin (Human) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Thrombin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Thrombin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Thrombin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Thrombin (Human) include Shanghai RAAS, Hualan Biological, Bayer, Baxter, Vitrolife AB, Sigma-Aldrich Corporation, PromoCell GmbH, Octapharma and Life Technologies Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Thrombin (Human) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Thrombin (Human) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Thrombin (Human) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Thrombin (Human).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Thrombin (Human) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Thrombin (Human) Market by Company

Shanghai RAAS

Hualan Biological

Bayer

Baxter

Vitrolife AB

Sigma-Aldrich Corporation

PromoCell GmbH

Octapharma

Life Technologies Corporation

Kedrion

Grifols

CSL

BD Biosciences

AMRESCO Inc

Thrombin (Human) Segment by Type

500IU/Vial

1000IU/Vial

2500IU/Vial

Thrombin (Human) Segment by Application

Biotechnology

Microbiology

Medicine

Others

Thrombin (Human) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thrombin (Human) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Thrombin (Human) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thrombin (Human).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Thrombin (Human) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Thrombin (Human) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 500IU/Vial Table 2. Major Company of 1000IU/Vial Table 3. Major Company of 2500IU/Vial Table 4. Global Thrombin (Human) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 6. Global Thrombin (Human) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Thrombin (Human) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Thrombin (Human) Sales Market Share in Value by Type (2021-2026) Table 9. Global Thrombin (Human) Price by Type (2021-2026) & (US$/Unit) Table 10. Global Thrombin (Human) Sales by Type (2027-2032) & (K Units) Table 11. Global Thrombin (Human) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Thrombin (Human) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Thrombin (Human) Sales Market Share in Value by Type (2027-2032) Table 14. Global Thrombin (Human) Price by Type (2027-2032) & (US$/Unit) Table 15. North America Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 16. North America Thrombin (Human) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 18. Europe Thrombin (Human) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Thrombin (Human) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 22. Latin America Thrombin (Human) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Thrombin (Human) Sales by Type (2021-2026) & (US$ Million) Table 25. Thrombin (Human) Industry Trends Table 26. Thrombin (Human) Industry Drivers Table 27. Thrombin (Human) Industry Opportunities and Challenges Table 28. Thrombin (Human) Industry Restraints Table 29. Global Thrombin (Human) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Thrombin (Human) Revenue Market Share by Company (2021-2026) Table 31. Global Thrombin (Human) Sales by Company (2021-2026) & (K Units) Table 32. Global Thrombin (Human) Sales Share by Company (2021-2026) Table 33. Global Thrombin (Human) Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Thrombin (Human) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Thrombin (Human) Major Company Production Sites and Headquarters Table 36. Global Thrombin (Human) Company, Product Type & Application Table 37. Global Thrombin (Human) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Thrombin (Human) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Thrombin (Human) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Thrombin (Human) Sales by Region (2021-2026) & (K Units) Table 42. Global Thrombin (Human) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Thrombin (Human) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Thrombin (Human) Sales Market Share in Value by Region (2021-2026) Table 45. Global Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Thrombin (Human) Sales by Region (2027-2032) & (K Units) Table 47. Global Thrombin (Human) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Thrombin (Human) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Thrombin (Human) Sales Market Share in Value by Region (2027-2032) Table 50. Global Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Thrombin (Human) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 53. Global Thrombin (Human) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Thrombin (Human) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Thrombin (Human) Sales Market Share in Value by Application (2021-2026) Table 56. Global Thrombin (Human) Price by Application (2021-2026) & (US$/Unit) Table 57. Global Thrombin (Human) Sales by Application (2027-2032) & (K Units) Table 58. Global Thrombin (Human) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Thrombin (Human) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Thrombin (Human) Sales Market Share in Value by Application (2027-2032) Table 61. Global Thrombin (Human) Price by Application (2027-2032) & (US$/Unit) Table 62. North America Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 63. North America Thrombin (Human) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 65. Europe Thrombin (Human) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Thrombin (Human) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 69. Latin America Thrombin (Human) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Thrombin (Human) Sales by Application (2021-2026) & (US$ Million) Table 72. Shanghai RAAS Company Information Table 73. Shanghai RAAS Business Overview Table 74. Shanghai RAAS Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Shanghai RAAS Thrombin (Human) Product Portfolio Table 76. Shanghai RAAS Recent Development Table 77. Hualan Biological Company Information Table 78. Hualan Biological Business Overview Table 79. Hualan Biological Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Hualan Biological Thrombin (Human) Product Portfolio Table 81. Hualan Biological Recent Development Table 82. Bayer Company Information Table 83. Bayer Business Overview Table 84. Bayer Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Bayer Thrombin (Human) Product Portfolio Table 86. Bayer Recent Development Table 87. Baxter Company Information Table 88. Baxter Business Overview Table 89. Baxter Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Baxter Thrombin (Human) Product Portfolio Table 91. Baxter Recent Development Table 92. Vitrolife AB Company Information Table 93. Vitrolife AB Business Overview Table 94. Vitrolife AB Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Vitrolife AB Thrombin (Human) Product Portfolio Table 96. Vitrolife AB Recent Development Table 97. Sigma-Aldrich Corporation Company Information Table 98. Sigma-Aldrich Corporation Business Overview Table 99. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sigma-Aldrich Corporation Thrombin (Human) Product Portfolio Table 101. Sigma-Aldrich Corporation Recent Development Table 102. PromoCell GmbH Company Information Table 103. PromoCell GmbH Business Overview Table 104. PromoCell GmbH Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. PromoCell GmbH Thrombin (Human) Product Portfolio Table 106. PromoCell GmbH Recent Development Table 107. Octapharma Company Information Table 108. Octapharma Business Overview Table 109. Octapharma Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Octapharma Thrombin (Human) Product Portfolio Table 111. Octapharma Recent Development Table 112. Life Technologies Corporation Company Information Table 113. Life Technologies Corporation Business Overview Table 114. Life Technologies Corporation Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Life Technologies Corporation Thrombin (Human) Product Portfolio Table 116. Life Technologies Corporation Recent Development Table 117. Kedrion Company Information Table 118. Kedrion Business Overview Table 119. Kedrion Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Kedrion Thrombin (Human) Product Portfolio Table 121. Kedrion Recent Development Table 122. Grifols Company Information Table 123. Grifols Business Overview Table 124. Grifols Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Grifols Thrombin (Human) Product Portfolio Table 126. Grifols Recent Development Table 127. CSL Company Information Table 128. CSL Business Overview Table 129. CSL Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. CSL Thrombin (Human) Product Portfolio Table 131. CSL Recent Development Table 132. BD Biosciences Company Information Table 133. BD Biosciences Business Overview Table 134. BD Biosciences Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. BD Biosciences Thrombin (Human) Product Portfolio Table 136. BD Biosciences Recent Development Table 137. AMRESCO Inc Company Information Table 138. AMRESCO Inc Business Overview Table 139. AMRESCO Inc Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. AMRESCO Inc Thrombin (Human) Product Portfolio Table 141. AMRESCO Inc Recent Development Table 142. North America Thrombin (Human) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. North America Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 144. North America Thrombin (Human) Sales Market Share by Country (2021-2026) Table 145. North America Thrombin (Human) Sales Forecast by Country (2027-2032) & (K Units) Table 146. North America Thrombin (Human) Sales Market Share Forecast by Country (2027-2032) Table 147. North America Thrombin (Human) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Thrombin (Human) Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Thrombin (Human) Market Share by Country (2021-2026) Table 150. North America Thrombin (Human) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Thrombin (Human) Market Share Forecast by Country (2027-2032) Table 152. Europe Thrombin (Human) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Europe Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 154. Europe Thrombin (Human) Sales Market Share by Country (2021-2026) Table 155. Europe Thrombin (Human) Sales Forecast by Country (2027-2032) & (K Units) Table 156. Europe Thrombin (Human) Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Thrombin (Human) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Thrombin (Human) Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Thrombin (Human) Market Share by Country (2021-2026) Table 160. Europe Thrombin (Human) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Thrombin (Human) Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Thrombin (Human) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 164. Asia-Pacific Thrombin (Human) Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Thrombin (Human) Sales Forecast by Country (2027-2032) & (K Units) Table 166. Asia-Pacific Thrombin (Human) Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Thrombin (Human) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Thrombin (Human) Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Thrombin (Human) Market Share by Country (2021-2026) Table 170. Asia-Pacific Thrombin (Human) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Thrombin (Human) Market Share Forecast by Country (2027-2032) Table 172. Latin America Thrombin (Human) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Latin America Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 174. Latin America Thrombin (Human) Sales Market Share by Country (2021-2026) Table 175. Latin America Thrombin (Human) Sales Forecast by Country (2027-2032) & (K Units) Table 176. Latin America Thrombin (Human) Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Thrombin (Human) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Thrombin (Human) Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Thrombin (Human) Market Share by Country (2021-2026) Table 180. Latin America Thrombin (Human) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Thrombin (Human) Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Thrombin (Human) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 184. Middle East and Africa Thrombin (Human) Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Thrombin (Human) Sales Forecast by Country (2027-2032) & (K Units) Table 186. Middle East and Africa Thrombin (Human) Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Thrombin (Human) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Thrombin (Human) Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Thrombin (Human) Market Share by Country (2021-2026) Table 190. Middle East and Africa Thrombin (Human) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Thrombin (Human) Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Thrombin (Human) Distributors List Table 195. Thrombin (Human) Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Thrombin (Human) Image Figure 2. Global Thrombin (Human) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Thrombin (Human) Market Size (2021-2032) & (US$ Million) Figure 4. Global Thrombin (Human) Sales (2021-2032) & (K Units) Figure 5. 500IU/Vial Image Figure 6. Global 500IU/Vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. 1000IU/Vial Image Figure 8. Global 1000IU/Vial Sales YoY Growth (2021-2032) & (K Units) Figure 9. 2500IU/Vial Image Figure 10. Global 2500IU/Vial Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Thrombin (Human) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Thrombin (Human) Market Share by Type 2025 VS 2032 Figure 13. North America Thrombin (Human) Sales Market Share in Volume by Type in 2025 Figure 14. North America Thrombin (Human) Sales Market Share in Value by Type in 2025 Figure 15. Europe Thrombin (Human) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Thrombin (Human) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Thrombin (Human) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Thrombin (Human) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Thrombin (Human) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Thrombin (Human) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Thrombin (Human) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Thrombin (Human) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Thrombin (Human) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Biotechnology Image Figure 26. Global Biotechnology Sales YoY Growth (2021-2032) & (K Units) Figure 27. Microbiology Image Figure 28. Global Microbiology Sales YoY Growth (2021-2032) & (K Units) Figure 29. Medicine Image Figure 30. Global Medicine Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Thrombin (Human) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Thrombin (Human) Market Share by Application 2025 VS 2032 Figure 35. North America Thrombin (Human) Sales Market Share in Volume by Application in 2025 Figure 36. North America Thrombin (Human) Sales Market Share in Value by Application in 2025 Figure 37. Europe Thrombin (Human) Sales Market Share in Volume by Application in 2025 Figure 38. Europe Thrombin (Human) Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Thrombin (Human) Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Thrombin (Human) Sales Market Share in Value by Application in 2025 Figure 41. Latin America Thrombin (Human) Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Thrombin (Human) Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Thrombin (Human) Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Thrombin (Human) Sales Market Share in Value by Application in 2025 Figure 45. North America Thrombin (Human) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Thrombin (Human) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Thrombin (Human) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Thrombin (Human) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Thrombin (Human) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Thrombin (Human) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Thrombin (Human) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Thrombin (Human) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Thrombin (Human) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Thrombin (Human) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Thrombin (Human) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Thrombin (Human) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Thrombin (Human) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Thrombin (Human) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Thrombin (Human) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Thrombin (Human) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Thrombin (Human) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Thrombin (Human) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Thrombin (Human) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Thrombin (Human) Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Thrombin (Human) Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Thrombin (Human) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 500IU/Vial
  • 1000IU/Vial
  • 2500IU/Vial
Applications
  • Biotechnology
  • Microbiology
  • Medicine
  • Others
Companies covered
  • Shanghai RAAS
  • Hualan Biological
  • Bayer
  • Baxter
  • Vitrolife AB
  • Sigma-Aldrich Corporation
  • PromoCell GmbH
  • Octapharma
  • Life Technologies Corporation
  • Kedrion
  • Grifols
  • CSL
  • BD Biosciences
  • AMRESCO Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Thrombin (Human) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Thrombin (Human) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Thrombin (Human) Market by Type
  6. 1.3.1 500IU/Vial
  7. 1.3.2 1000IU/Vial
  8. 1.3.3 2500IU/Vial
  9. 1.4 Global Thrombin (Human) Market Size by Type
  10. 1.4.1 Global Thrombin (Human) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Thrombin (Human) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Thrombin (Human) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Thrombin (Human) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Thrombin (Human) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Thrombin (Human) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Thrombin (Human) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Thrombin (Human) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Thrombin (Human) Industry Trends
  2. 2.2 Thrombin (Human) Industry Drivers
  3. 2.3 Thrombin (Human) Industry Opportunities and Challenges
  4. 2.4 Thrombin (Human) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Thrombin (Human) Revenue (2021-2026)
  2. 3.2 Global Top Players by Thrombin (Human) Sales (2021-2026)
  3. 3.3 Global Top Players by Thrombin (Human) Price (2021-2026)
  4. 3.4 Global Thrombin (Human) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Thrombin (Human) Major Company Production Sites & Headquarters
  6. 3.6 Global Thrombin (Human) Company, Product Type & Application
  7. 3.7 Global Thrombin (Human) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Thrombin (Human) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Thrombin (Human) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Thrombin (Human) Tier 1, Tier 2, and Tier 3
4 Thrombin (Human) Regional Status and Outlook
  1. 4.1 Global Thrombin (Human) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Thrombin (Human) Historic Market Size by Region
  3. 4.2.1 Global Thrombin (Human) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Thrombin (Human) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Thrombin (Human) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Thrombin (Human) Forecasted Market Size by Region
  7. 4.3.1 Global Thrombin (Human) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Thrombin (Human) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Thrombin (Human) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Thrombin (Human) by Application
  1. 5.1 Thrombin (Human) Market by Application
  2. 5.1.1 Biotechnology
  3. 5.1.2 Microbiology
  4. 5.1.3 Medicine
  5. 5.1.4 Others
  6. 5.2 Global Thrombin (Human) Market Size by Application
  7. 5.2.1 Global Thrombin (Human) Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Thrombin (Human) Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Thrombin (Human) Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Thrombin (Human) Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Thrombin (Human) Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Thrombin (Human) Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Thrombin (Human) Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Thrombin (Human) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai RAAS
  2. 6.1.1 Shanghai RAAS Company Information
  3. 6.1.2 Shanghai RAAS Business Overview
  4. 6.1.3 Shanghai RAAS Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai RAAS Thrombin (Human) Product Portfolio
  6. 6.1.5 Shanghai RAAS Recent Developments
  7. 6.2 Hualan Biological
  8. 6.2.1 Hualan Biological Company Information
  9. 6.2.2 Hualan Biological Business Overview
  10. 6.2.3 Hualan Biological Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hualan Biological Thrombin (Human) Product Portfolio
  12. 6.2.5 Hualan Biological Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Thrombin (Human) Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 Baxter
  20. 6.4.1 Baxter Company Information
  21. 6.4.2 Baxter Business Overview
  22. 6.4.3 Baxter Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Baxter Thrombin (Human) Product Portfolio
  24. 6.4.5 Baxter Recent Developments
  25. 6.5 Vitrolife AB
  26. 6.5.1 Vitrolife AB Company Information
  27. 6.5.2 Vitrolife AB Business Overview
  28. 6.5.3 Vitrolife AB Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Vitrolife AB Thrombin (Human) Product Portfolio
  30. 6.5.5 Vitrolife AB Recent Developments
  31. 6.6 Sigma-Aldrich Corporation
  32. 6.6.1 Sigma-Aldrich Corporation Company Information
  33. 6.6.2 Sigma-Aldrich Corporation Business Overview
  34. 6.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sigma-Aldrich Corporation Thrombin (Human) Product Portfolio
  36. 6.6.5 Sigma-Aldrich Corporation Recent Developments
  37. 6.7 PromoCell GmbH
  38. 6.7.1 PromoCell GmbH Company Information
  39. 6.7.2 PromoCell GmbH Business Overview
  40. 6.7.3 PromoCell GmbH Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 PromoCell GmbH Thrombin (Human) Product Portfolio
  42. 6.7.5 PromoCell GmbH Recent Developments
  43. 6.8 Octapharma
  44. 6.8.1 Octapharma Company Information
  45. 6.8.2 Octapharma Business Overview
  46. 6.8.3 Octapharma Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Octapharma Thrombin (Human) Product Portfolio
  48. 6.8.5 Octapharma Recent Developments
  49. 6.9 Life Technologies Corporation
  50. 6.9.1 Life Technologies Corporation Company Information
  51. 6.9.2 Life Technologies Corporation Business Overview
  52. 6.9.3 Life Technologies Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Life Technologies Corporation Thrombin (Human) Product Portfolio
  54. 6.9.5 Life Technologies Corporation Recent Developments
  55. 6.10 Kedrion
  56. 6.10.1 Kedrion Company Information
  57. 6.10.2 Kedrion Business Overview
  58. 6.10.3 Kedrion Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Kedrion Thrombin (Human) Product Portfolio
  60. 6.10.5 Kedrion Recent Developments
  61. 6.11 Grifols
  62. 6.11.1 Grifols Company Information
  63. 6.11.2 Grifols Business Overview
  64. 6.11.3 Grifols Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Grifols Thrombin (Human) Product Portfolio
  66. 6.11.5 Grifols Recent Developments
  67. 6.12 CSL
  68. 6.12.1 CSL Company Information
  69. 6.12.2 CSL Business Overview
  70. 6.12.3 CSL Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CSL Thrombin (Human) Product Portfolio
  72. 6.12.5 CSL Recent Developments
  73. 6.13 BD Biosciences
  74. 6.13.1 BD Biosciences Company Information
  75. 6.13.2 BD Biosciences Business Overview
  76. 6.13.3 BD Biosciences Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 BD Biosciences Thrombin (Human) Product Portfolio
  78. 6.13.5 BD Biosciences Recent Developments
  79. 6.14 AMRESCO Inc
  80. 6.14.1 AMRESCO Inc Company Information
  81. 6.14.2 AMRESCO Inc Business Overview
  82. 6.14.3 AMRESCO Inc Thrombin (Human) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 AMRESCO Inc Thrombin (Human) Product Portfolio
  84. 6.14.5 AMRESCO Inc Recent Developments
7 North America by Country
  1. 7.1 North America Thrombin (Human) Sales by Country
  2. 7.1.1 North America Thrombin (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Thrombin (Human) Sales by Country (2021-2026)
  4. 7.1.3 North America Thrombin (Human) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Thrombin (Human) Market Size by Country
  6. 7.2.1 North America Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Thrombin (Human) Market Size by Country (2021-2026)
  8. 7.2.3 North America Thrombin (Human) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Thrombin (Human) Sales by Country
  2. 8.1.1 Europe Thrombin (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Thrombin (Human) Sales by Country (2021-2026)
  4. 8.1.3 Europe Thrombin (Human) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Thrombin (Human) Market Size by Country
  6. 8.2.1 Europe Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Thrombin (Human) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Thrombin (Human) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Thrombin (Human) Sales by Country
  2. 9.1.1 Asia-Pacific Thrombin (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Thrombin (Human) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Thrombin (Human) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Thrombin (Human) Market Size by Country
  6. 9.2.1 Asia-Pacific Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Thrombin (Human) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Thrombin (Human) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Thrombin (Human) Sales by Country
  2. 10.1.1 South America Thrombin (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Thrombin (Human) Sales by Country (2021-2026)
  4. 10.1.3 South America Thrombin (Human) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Thrombin (Human) Market Size by Country
  6. 10.2.1 South America Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Thrombin (Human) Market Size by Country (2021-2026)
  8. 10.2.3 South America Thrombin (Human) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Thrombin (Human) Sales by Country
  2. 11.1.1 Middle East and Africa Thrombin (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Thrombin (Human) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Thrombin (Human) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Thrombin (Human) Market Size by Country
  6. 11.2.1 Middle East and Africa Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Thrombin (Human) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Thrombin (Human) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Thrombin (Human) Value Chain Analysis
  2. 12.1.1 Thrombin (Human) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Thrombin (Human) Production Mode & Process
  7. 12.2 Thrombin (Human) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Thrombin (Human) Distributors
  10. 12.2.3 Thrombin (Human) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst